Replies to post #9764 on iBio Inc (IBIO)

[apostrophe]

Looks like there is good reason why ZMapp is considered "the most promising candidate so far".

[...]
"Two other small U.S. biotech companies, Chimerix (CMRX) and Mapp Biopharmaceuticals, are working on "antiviral" treatments for Ebola.

Thomas Duncan, the first person diagnosed with the disease on U.S. soil, was treated with a drug called Brincidofovir, made by Chimerix. He did not survive.

Patients at Emory University in Atlanta appear to have been helped by ZMapp, an experimental drug made by Mapp Biopharmaceutical. "
[...]

http://money.cnn.com/2014/10/28/news/companies/ebola-drug-billion/index.html